. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease. Biotech Histochem. 2002 Mar;77(2):95-103. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. Please see also the following letter in Science discussing the role of amyloid in Alzheimer's disease:

    Alzheimer's disease and amyloid beta protein
    Koudinov AR et al
    Science online, Published 25 June 2002
    [ Full Text ]

Make a Comment

To make a comment you must login or register.